BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 30251126)

  • 21. Factors associated with symptom severity in women presenting with fecal incontinence.
    Menees SB; Smith TM; Xu X; Chey WD; Saad RJ; Fenner DE
    Dis Colon Rectum; 2013 Jan; 56(1):97-102. PubMed ID: 23222286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into normal and disordered bowel habits from bowel diaries.
    Bharucha AE; Seide BM; Zinsmeister AR; Melton LJ
    Am J Gastroenterol; 2008 Mar; 103(3):692-8. PubMed ID: 18021288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal incontinence in irritable bowel syndrome: Prevalence and associated factors in Swedish and American patients.
    Simrén M; Palsson OS; Heymen S; Bajor A; Törnblom H; Whitehead WE
    Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27581702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Patient Impact and Clinical Characteristics Between Urgency and Passive Fecal Incontinence Phenotypes.
    Pahwa AK; Khanijow KD; Harvie HS; Arya LA; Andy UU
    Female Pelvic Med Reconstr Surg; 2020 Sep; 26(9):570-574. PubMed ID: 29979355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life is markedly improved in patients with fecal incontinence after sacral nerve stimulation.
    Devroede G; Giese C; Wexner SD; Mellgren A; Coller JA; Madoff RD; Hull T; Stromberg K; Iyer S;
    Female Pelvic Med Reconstr Surg; 2012; 18(2):103-12. PubMed ID: 22453321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study of transcutaneous sacral nerve stimulation for faecal incontinence.
    Thomas GP; Norton C; Nicholls RJ; Vaizey CJ
    Colorectal Dis; 2013 Nov; 15(11):1406-9. PubMed ID: 23910042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The test-retest reliability of fecal incontinence severity and quality-of-life assessment tools.
    Hussain ZI; Lim M; Stojkovic S
    Dis Colon Rectum; 2014 May; 57(5):638-44. PubMed ID: 24819105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics Associated With Clinically Important Treatment Responses in Women Undergoing Nonsurgical Therapy for Fecal Incontinence.
    Richter HE; Jelovsek JE; Iyer P; Rogers RG; Meyer I; Newman DK; Bradley MS; Harm-Ernandes I; Dyer KY; Wohlrab K; Mazloomdoost D; Gantz MG;
    Am J Gastroenterol; 2020 Jan; 115(1):115-127. PubMed ID: 31895722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology of fecal incontinence in obese patients: A prospective case-matched study of 201 patients.
    Brochard C; Vénara A; Bodère A; Ropert A; Bouguen G; Siproudhis L
    Neurogastroenterol Motil; 2017 Aug; 29(8):. PubMed ID: 28229523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Faecal incontinence intervention study (FINS): self-management booklet information with or without nurse support to improve continence in people with inflammatory bowel disease: study protocol for a randomized controlled trial.
    Norton C; Dibley LB; Hart A; Duncan J; Emmanuel A; Knowles CH; Stevens N; Terry H; Verjee A; Kerry S; Hounsome N
    Trials; 2015 Oct; 16():444. PubMed ID: 26445224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the St. Mark's incontinence score reflect patients' perceptions? A review of 390 patients.
    Maeda Y; Parés D; Norton C; Vaizey CJ; Kamm MA
    Dis Colon Rectum; 2008 Apr; 51(4):436-42. PubMed ID: 18219532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholestyramine--a useful adjunct for the treatment of patients with fecal incontinence.
    Remes-Troche JM; Ozturk R; Philips C; Stessman M; Rao SS
    Int J Colorectal Dis; 2008 Feb; 23(2):189-94. PubMed ID: 17938939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of methylcellulose and loperamide in managing fecal incontinence.
    Sze EH; Hobbs G
    Acta Obstet Gynecol Scand; 2009; 88(7):766-71. PubMed ID: 19452328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Nonoperative Management of Chronic Anal Fissure and Hemorrhoid Disease on Bowel Function Patient-Reported Outcomes.
    Wilson MZ; Swarup A; T Wilson LR; Ivatury SJ
    Dis Colon Rectum; 2018 Oct; 61(10):1223-1227. PubMed ID: 30192331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biofeedback therapy for symptoms of bowel dysfunction following surgery for colorectal cancer.
    Bartlett L; Sloots K; Nowak M; Ho YH
    Tech Coloproctol; 2011 Sep; 15(3):319-26. PubMed ID: 21755415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Randomized Pilot Study to Compare the Effectiveness of a Low FODMAP Diet vs Psyllium in Patients With Fecal Incontinence and Loose Stools.
    Menees SB; Jackson K; Baker JR; Fenner DE; Eswaran S; Nojkov B; Saad R; Lee AA; Chey WD
    Clin Transl Gastroenterol; 2022 Feb; 13(3):e00454. PubMed ID: 35060943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bowel habits and fecal incontinence in patients with obesity undergoing evaluation for weight loss: the importance of stool consistency.
    Parés D; Vallverdú H; Monroy G; Amigo P; Romagosa C; Toral M; Hermoso J; Saenz-de-Navarrete G
    Dis Colon Rectum; 2012 May; 55(5):599-604. PubMed ID: 22513439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary changes in bowel function after successful treatment of voiding symptoms with neuromodulation.
    Killinger KA; Kangas JR; Wolfert C; Boura JA; Peters KM
    Neurourol Urodyn; 2011 Jan; 30(1):133-7. PubMed ID: 20928914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The procon incontinence device: a new nonsurgical approach to preventing episodes of fecal incontinence.
    Giamundo P; Welber A; Weiss EG; Vernava AM; Nogueras JJ; Wexner SD
    Am J Gastroenterol; 2002 Sep; 97(9):2328-32. PubMed ID: 12358252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validating endpoints for therapeutic trials in fecal incontinence.
    Noelting J; Zinsmeister AR; Bharucha AE
    Neurogastroenterol Motil; 2016 Aug; 28(8):1148-56. PubMed ID: 26948292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.